Stefan M. Larson, PhD has served as a member of our board of directors since November 2019. Dr. Larson has served as partner at Sectoral Asset Management, responsible for leading biotechnology venture investments, since September 2018. He also serves on the boards of directors of eFFECTOR Therapeutics (since September 2018), Turnstone Biologics (since January 2019), and Prilenia Therapeutics BV (since May 2020). Prior to joining Sectoral Asset Management, he was an Entrepreneur-in-Residence and later Venture Partner with Versant Ventures (from July 2013 to July 2018), where he led the establishment of their Toronto-based Discovery Engine. He was also the founding CEO of Northern Biologics (from January 2015 to November 2017) and a cofounder of two medical device companies: Perimeter Medical Imaging (from January 2010 to December 2012), and Tornado Spectral Systems (from January 2010 to December 2012). He began his career at McKinsey & Company in San Francisco and Toronto. Dr. Larson graduated in 1997 from McGill University with a B.Sc. in Biology, and in 1999 from University of Toronto with an M.Sc. in Molecular and Medical Genetics. He completed his PhD in Biophysics at Stanford University in 2004.